Literature DB >> 10914377

Implantable defibrillator therapy in Naxos disease.

K Gatzoulis1, N Protonotarios, A Anastasakis, A Tsatsopoulou, J Vlasseros, J Gialafos, P Toutouzas.   

Abstract

Naxos disease is a unique form of right ventricular cardiomyopathy with a high prevalence of malignant ventricular arrhythmias, including sudden cardiac death. As a hereditary systemic disease confined to a small island, it has been closely studied over the last 15 years. The implantation of an automatic defibrillator provides an alternative form of antiarrhythmic management to improve life expectancy in these high risk cardiac patients. We present the first two Naxos disease patients with malignant ventricular arrhythmias who had defibrillator implantation.

Entities:  

Mesh:

Year:  2000        PMID: 10914377     DOI: 10.1111/j.1540-8159.2000.tb00922.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

Review 1.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment.

Authors:  E E van der Wall; M Bootsma; H J J Wellens; J J Bax; A de Roos; M J Schalij
Journal:  Neth Heart J       Date:  2003-01       Impact factor: 2.380

2.  A case of arrhythmogenic right ventricular cardiomyopathy-Naxos disease.

Authors:  R R Saravanan; V Amuthan; R A Janarthanan; S Balasubramanian; S Naina Mohamed
Journal:  Indian Heart J       Date:  2012-03-26

3.  Naxos disease in two siblings.

Authors:  G Meera; D Prabhavathy; S Jayakumar; Gk Tharini
Journal:  Int J Trichology       Date:  2010-01

Review 4.  Naxos disease: cardiocutaneous syndrome due to cell adhesion defect.

Authors:  Nikos Protonotarios; Adalena Tsatsopoulou
Journal:  Orphanet J Rare Dis       Date:  2006-03-13       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.